Heme Inhibits Human Neutrophil Apoptosis: Involvement of Phosphoinositide 3-Kinase, MAPK, and NF-κB
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
High levels of free heme are found in pathological states of increased hemolysis, such as sickle cell disease, malaria, and ischemia reperfusion. The hemolytic events are often associated with an inflammatory response that usually turns into chronic inflammation. We recently reported that heme is a proinflammatory molecule, able to induce neutrophil migration, reactive oxygen species generation, and IL-8 expression. In this study, we show that heme (1–50 μM) delays human neutrophil spontaneous apoptosis in vitro. This effect requires heme oxygenase activity, and depends on reactive oxygen species production and on de novo protein synthesis. Inhibition of ERK and PI3K pathways abolished heme-protective effects upon human neutrophils, suggesting the involvement of the Ras/Raf/MAPK and PI3K pathway on this effect. Confirming the involvement of these pathways in the modulation of the antiapoptotic effect, heme induces Akt phosphorylation and ERK-2 nuclear translocation in neutrophils. Futhermore, inhibition of NF-κB translocation reversed heme antiapoptotic effect. NF-κB (p65 subunit) nuclear translocation and IκB degradation were also observed in heme-treated cells, indicating that free heme may regulate neutrophil life span modulating signaling pathways involved in cell survival. Our data suggest that free heme associated with hemolytic episodes might play an important role in the development of chronic inflammation by interfering with the longevity of neutrophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 2×
“(1), neutrophils incubated for 20 h in the absence (2) or the presence of 3”
BackgroundChoi, A. M., & Alam, J. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.15.1.8679227 · Cited by 1,126
Lee, A., Whyte, M. K. B., & Haslett, C. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.4.283 · Cited by 714
Brouard, S., Berberat, P. O., Tobiasch, E., Seldon, M. P., Bach, F. H., & Soares, M. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108317200 · Cited by 306 · cited 1×
“Recent reports have shown that the induction of HO-1 activity inhibited TNF- -induced apoptosis in endothelial cell, via CO generation (37), whereas E-selectin and VCAM expression promoted by this stimulus is negatively modulated by HO-1 activity via bilirubin and Fe (38).”
Background
Research works printed but not linked: 55
- 1993, Am. J. Hematol., 59
- 2002, Nat. Med., 1383
- 2002, Blood, 4160
- 1996, Acta Obstet. Gynecol. Scand., 695
- 1990, Blood, 2439
- 1994, Transfus. Med. Rev., 157
- 1998, Blood, 3423
- 2001, Braz. J. Med. Biol. Res., 1309
- 2001, Hematology, 403
- 2000, J. Clin. Invest., 411
- 1997, J. Leukocyte Biol., 375
- 1999, Trends Pharmacol. Sci., 503
- 2000, Biochemistry and Physiology of the Neutrophil
- 2002, Nat. Rev. Immunol., 965
- 2000, Nature, 770
- 1998, Kidney Int., 84
- 1993, J. Leukocyte Biol., 283
- 1992, Blood, 2012
- 1996, J. Immunol., 3105
- 2000, J. Immunol., 4286
- 2001, Cell. Signal., 335
- 1999, J. Biol. Chem., 4309
- 2001, FEBS Lett., 318
- 1976, Scand. J. Immunol. (Suppl., 9
- 1995, Mediat. Inflamm., 222
- 2001, FASEB J., 1643
- 1976, Anal. Biochem., 248
- 1998, Blood, 4808
- 1998, Blood, 2249
- 2002, Clin. Microbiol. Rev., 414
- 2002, Immunology, 306
- 1999, Blood, 4006
- 1996, Am. J. Respir. Cell Mol. Biol., 9
- 2000, Int. J. Immunopharmacol., 1131
- 2003, Pharmacol. Rev., 551
- 1999, Am. J. Physiol., L688
- 2002, J. Biol. Chem., 17950
- 2004, J. Immunol., 3553
- 1993, Cell, 241
- 1997, FEBS Lett., 552
- 2002, J. Leukocyte Biol., 207
- 2002, Antioxid. Redox Signal., 97
- 2001, J. Biol. Chem., 45041
- 1999, J. Biol. Chem., 37329
- 2000, Exp. Cell Res., 34
- 1999, Clin. Chem. Lab. Med., 205
- 2001, J. Clin. Invest., 3
- 2001, J. Clin. Invest., 135
- 1999, Oncogene, 6910
- 2000, Biochem. Pharmacol., 1033
- 2001, J. Biol. Chem., 19746
- 2002, J. Immunol., 3947
- 2002, Crit. Care, 481
- 2004, J. Immunol., 2522
- 2002, Am. J. Physiol., L815
Cited by
Mechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241
“Activation of p38 MAPK by HO-1 also induces the expression of Bcl-xL via the phosphatidylinositol-3-kinase (PI3K/Akt) signal transduction pathway (104, 105), an effect that should inhibit the intrinsic (mitochondrial) apoptotic pathway (Figure 3).”
BackgroundFree heme toxicity and its detoxification systems in human
Kumar, S., & Bandyopadhyay, U. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.03.004 · Cited by 852
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality
Remijsen, Q., Kuijpers, T. W., Wirawan, E., Lippens, S., Vandenabeele, P., & Vanden Berghe, T. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.1 · Cited by 607
Oh, G.-S., Pae, H.-O., Lee, B.-S., Kim, B.-N., Kim, J.-M., Kim, H.-R., Jeon, S. B., Jeon, W. K., Chae, H.-J., & Chung, H.-T. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.03.021 · Cited by 420
Metadata
- Authors
- Arruda, M. A., Rossi, A. G., de Freitas, M. S., Barja-Fidalgo, C., & Graça-Souza, A. V.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 173
- Issue
- 3
- Pages
- 2023-2030
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1903666634
- Cited by
- 147
- References
- 4
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.